Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies
about
Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefitsRab11 regulates trafficking of trans-sialidase to the plasma membrane through the contractile vacuole complex of Trypanosoma cruziLytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruziPossible role of a cell surface carbohydrate in evolution of resistance to viral infections in old world primatesThe Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevanceInefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cellsEnhancing glycan isomer separations with metal ions and positive and negative polarity ion mobility spectrometry-mass spectrometry analyses.A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas diseaseCD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development?Extracellular vesicles in parasitic diseasesAnti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions.Passive transfer of a monoclonal antibody specific for a sialic acid-dependent epitope on the surface of Trypanosoma cruzi trypomastigotes reduces infection in miceImproved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi.Vesicle and vesicle-free extracellular proteome of Paracoccidioides brasiliensis: comparative analysis with other pathogenic fungi.Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of α-galactosyl residues.Functionally distinct roles for glycosylation of alpha and beta integrin chains in cell-matrix interactions.Vesicles from different Trypanosoma cruzi strains trigger differential innate and chronic immune responses.Synthesis of Galα(1,3)Galβ(1,4)GlcNAcα-, Galβ(1,4)GlcNAcα- and GlcNAc-containing neoglycoproteins and their immunological evaluation in the context of Chagas disease.A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody.Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease.A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.Evaluation of a chemiluminescent enzyme-linked immunosorbent assay for the diagnosis of Trypanosoma cruzi infection in a nonendemic settingCross-reactivity of anti-galactocerebroside autoantibodies with a Trypanosoma brucei proteolipidic epitope.Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents.O-glycosidically linked N-acetylglucosamine-bound oligosaccharides from glycoproteins of Trypanosoma cruzi.Virus-like Particle Display of the α-Gal Carbohydrate for Vaccination against Leishmania Infection.The pathogenic fungus Paracoccidioides brasiliensis exports extracellular vesicles containing highly immunogenic α-Galactosyl epitopes.An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major.Immunity to α-Gal: The Opportunity for Malaria and Tuberculosis Control.Immunity to α-Gal: Toward a Single-Antigen Pan-Vaccine To Control Major Infectious Diseases.The emerging role of complement lectin pathway in trypanosomatids: molecular bases in activation, genetic deficiencies, susceptibility to infection, and complement system-based therapeutics.The Unsolved Jigsaw Puzzle of the Immune Response in Chagas DiseaseAutoimmunity in Chronic Chagas Disease: A Road of Multiple Pathways to Cardiomyopathy?Trypanosoma cruzi infection enhances polyreactive antibody response in an acute case of human Chagas' disease
P2860
Q27021788-D9221DE4-F96B-45D6-878F-95AC3027F7B8Q27324721-C6D7A260-F61C-4C83-B845-8248B72F0559Q28368291-530EDD72-2E58-4027-A09C-C71A7A202FBDQ28675345-7A1C211A-9BC9-4771-A042-68F3C600EDC9Q28755302-F3E9C063-743C-44CD-A5E2-F139C3303401Q33543089-BAC40778-5251-47C9-9532-CEE2978F7902Q33698046-B296F077-F118-4B5A-917A-CD6BBEA977E2Q33760119-C05E7D77-FF28-4D8E-971A-3EEEE1A74949Q33914939-23819340-C7F8-4B03-B8A9-578240C4CA8FQ34767634-95A49E1A-A4C2-42FE-9DE6-06CA080312B7Q35224124-28E11341-2E54-4011-934C-A9C6104779B5Q35550279-405C3C0B-A041-4403-9EC2-FAED6FF2887BQ35660798-FB341CEE-E2F5-4BD9-B924-E65B34E527B7Q35869182-E1249898-6C7C-4D36-A6AC-AD5E0EA948C7Q36080155-4C0C9175-8C32-444F-A075-A0668EB8BD5BQ36132010-7A8B186D-109C-4DF3-8249-DA5690ACD736Q36326969-2DBFA1A9-7BBC-48DC-94E5-EFA02FAC2C8CQ36353119-C1AC23C2-C53D-4E29-8A7F-AA55F49BEDB5Q36365516-691EAE40-8277-4EA1-B1B2-A2DC01513E86Q36523785-D2D74712-CE6A-4EEB-A758-35912E7C1F74Q37130755-0E51725E-36BB-4FC5-9C74-322906F0B876Q38567777-40D343E1-E7D6-4DC3-8A75-FF6316881AB9Q39024442-1919F72C-E8B6-4D8B-A736-B0728B2BE33BQ40410786-9D2A1410-39C5-48E5-9D91-64BCEAA011C4Q41859000-CE24B78D-CC44-44C9-BEC7-BF56B38F62C3Q41894108-931AA5BA-1A7C-4F22-A05A-72E01560B088Q41984033-98F7460C-336F-4E39-8F43-B92AEF987DC9Q46275091-8950B586-7A67-406A-8DD7-7A1AC0B62147Q47135299-4A4A3919-4FF8-42F5-85B6-018E5E2895E3Q49231090-15579002-A255-41C7-816B-6C0E35B7FB8FQ55686634-57291C17-52BA-4678-819B-64A4A78FB5E6Q58705710-6DA2292E-798B-4DF3-A241-8074C73FB211Q58799039-77F77AFC-62F6-47F1-ACBB-170612FC2E1EQ58844231-F0E7A48A-E39C-4BD2-B69B-21283C1E0BB1
P2860
Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies
description
1991 nî lūn-bûn
@nan
1991 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Complement-mediated lysis of T ...... ti-alpha-galactosyl antibodies
@ast
Complement-mediated lysis of T ...... ti-alpha-galactosyl antibodies
@en
Complement-mediated lysis of T ...... ti-alpha-galactosyl antibodies
@nl
type
label
Complement-mediated lysis of T ...... ti-alpha-galactosyl antibodies
@ast
Complement-mediated lysis of T ...... ti-alpha-galactosyl antibodies
@en
Complement-mediated lysis of T ...... ti-alpha-galactosyl antibodies
@nl
prefLabel
Complement-mediated lysis of T ...... ti-alpha-galactosyl antibodies
@ast
Complement-mediated lysis of T ...... ti-alpha-galactosyl antibodies
@en
Complement-mediated lysis of T ...... ti-alpha-galactosyl antibodies
@nl
P2093
P1476
Complement-mediated lysis of T ...... ti-alpha-galactosyl antibodies
@en
P2093
I C Almeida
L R Travassos
S R Milani
P304
P407
P577
1991-04-01T00:00:00Z